[go: up one dir, main page]

NO20031754D0 - Fremgangsmåte for fremstilling av mesylater av piperzinderivater - Google Patents

Fremgangsmåte for fremstilling av mesylater av piperzinderivater

Info

Publication number
NO20031754D0
NO20031754D0 NO20031754A NO20031754A NO20031754D0 NO 20031754 D0 NO20031754 D0 NO 20031754D0 NO 20031754 A NO20031754 A NO 20031754A NO 20031754 A NO20031754 A NO 20031754A NO 20031754 D0 NO20031754 D0 NO 20031754D0
Authority
NO
Norway
Prior art keywords
mesylates
preparation
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
NO20031754A
Other languages
English (en)
Other versions
NO20031754L (no
NO324460B1 (no
Inventor
Marcel P M Van Aar
Stefanus J Schouten
Jan Zorgdrager
Michiel C Heslinga
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20031754L publication Critical patent/NO20031754L/no
Publication of NO20031754D0 publication Critical patent/NO20031754D0/no
Publication of NO324460B1 publication Critical patent/NO324460B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20031754A 2001-02-16 2003-04-15 Fremgangsmate for fremstilling av mesylater av piperazinderivater NO324460B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200534 2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Publications (3)

Publication Number Publication Date
NO20031754L NO20031754L (no) 2003-04-15
NO20031754D0 true NO20031754D0 (no) 2003-04-15
NO324460B1 NO324460B1 (no) 2007-10-22

Family

ID=8179894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031754A NO324460B1 (no) 2001-02-16 2003-04-15 Fremgangsmate for fremstilling av mesylater av piperazinderivater

Country Status (34)

Country Link
US (1) US7030241B2 (no)
EP (1) EP1362040B1 (no)
JP (1) JP4328528B2 (no)
KR (2) KR100859106B1 (no)
CN (1) CN1176079C (no)
AR (1) AR034206A1 (no)
AT (1) ATE284875T1 (no)
AU (1) AU2002250962B2 (no)
BG (1) BG66101B1 (no)
BR (1) BR0205683A (no)
CA (1) CA2422703C (no)
CZ (1) CZ301780B6 (no)
DE (1) DE60202261T2 (no)
DK (1) DK1362040T3 (no)
DZ (1) DZ3489A1 (no)
ES (1) ES2230481T3 (no)
HR (1) HRP20030610B1 (no)
HU (1) HUP0400772A3 (no)
IL (1) IL153509A (no)
IS (1) IS2417B (no)
ME (1) MEP37508A (no)
MX (1) MXPA03002359A (no)
MY (1) MY130687A (no)
NO (1) NO324460B1 (no)
NZ (1) NZ524632A (no)
PL (1) PL208363B1 (no)
PT (1) PT1362040E (no)
RS (1) RS51126B (no)
RU (1) RU2272036C2 (no)
SI (1) SI1362040T1 (no)
SK (1) SK286143B6 (no)
UA (1) UA75390C2 (no)
WO (1) WO2002066449A2 (no)
ZA (1) ZA200301590B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045362A1 (es) * 2003-08-18 2005-10-26 Solvay Pharm Bv Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) * 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
AU2007291235A1 (en) 2006-08-31 2008-03-06 H. Lundbeck A/S Bifeprunox doses for treating schizophrenia
US20080132520A1 (en) * 2006-08-31 2008-06-05 Winsemius Antje A Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
US20090068290A1 (en) * 2006-08-31 2009-03-12 Michel Bourin Bifeprunox doses for treating schizophrenia
EP2249838A4 (en) 2008-02-05 2012-05-02 Harbor Biosciences Inc Pharmaceutical solid state forms
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UY32935A (es) 2009-10-12 2011-05-31 Abbott Healthcare Products Bv Polimorfos de pardoprunox

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190472B1 (en) * 1984-12-21 1989-07-12 Duphar International Research B.V New pharmaceutical compositions having anti-psychotic properties
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH0344383A (ja) * 1989-07-12 1991-02-26 Ihara Chem Ind Co Ltd 5―トリフルオロメチル―2―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) * 1990-05-22 2000-05-22 コニカ株式会社 含窒素6員環化合物の製造方法
GB9200293D0 (en) * 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
AU708053B2 (en) * 1996-03-29 1999-07-29 Duphar International Research B.V. Piperazine and piperidine compounds
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
UA71590C2 (en) 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US7435738B2 (en) * 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Also Published As

Publication number Publication date
SK286143B6 (sk) 2008-04-07
CZ301780B6 (cs) 2010-06-23
BR0205683A (pt) 2004-07-06
KR20030077523A (ko) 2003-10-01
KR100859106B1 (ko) 2008-09-18
US20040077631A1 (en) 2004-04-22
PL369330A1 (en) 2005-04-18
AR034206A1 (es) 2004-02-04
ZA200301590B (en) 2004-02-05
CN1463268A (zh) 2003-12-24
NO20031754L (no) 2003-04-15
MXPA03002359A (es) 2003-06-30
HRP20030610A2 (en) 2005-06-30
JP2004518741A (ja) 2004-06-24
ATE284875T1 (de) 2005-01-15
WO2002066449A2 (en) 2002-08-29
EP1362040A2 (en) 2003-11-19
PT1362040E (pt) 2005-05-31
YU64403A (sh) 2006-05-25
CZ2003697A3 (cs) 2003-06-18
KR101000733B1 (ko) 2010-12-14
BG66101B1 (bg) 2011-04-29
RS51126B (sr) 2010-10-31
IL153509A (en) 2007-12-03
HK1059934A1 (en) 2004-07-23
IS6876A (is) 2003-07-17
PL208363B1 (pl) 2011-04-29
NZ524632A (en) 2004-03-26
US7030241B2 (en) 2006-04-18
HUP0400772A2 (hu) 2004-08-30
BG108090A (bg) 2004-12-30
DZ3489A1 (fr) 2002-08-29
DE60202261T2 (de) 2005-05-19
CA2422703C (en) 2010-04-13
SK3092003A3 (en) 2003-09-11
RU2272036C2 (ru) 2006-03-20
IS2417B (is) 2008-10-15
CA2422703A1 (en) 2002-08-29
WO2002066449A3 (en) 2002-10-24
HUP0400772A3 (en) 2008-02-28
HRP20030610B1 (en) 2006-02-28
JP4328528B2 (ja) 2009-09-09
CN1176079C (zh) 2004-11-17
SI1362040T1 (en) 2005-06-30
KR20080064206A (ko) 2008-07-08
EP1362040B1 (en) 2004-12-15
MY130687A (en) 2007-07-31
DK1362040T3 (da) 2005-01-24
UA75390C2 (en) 2006-04-17
AU2002250962B2 (en) 2006-08-24
MEP37508A (en) 2011-02-10
DE60202261D1 (de) 2005-01-20
IL153509A0 (en) 2003-07-06
ES2230481T3 (es) 2005-05-01
NO324460B1 (no) 2007-10-22

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
FI20011541A0 (fi) Menetelmä massan valmistamiseksi
NO20031754L (no) Fremgangsmåte for fremstilling av mesylater av piperzinderivater
IL160043A0 (en) Process for the preparation of indole derivatives
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
IL159304A0 (en) Process for the production of piperidine derivatives
NO20031413D0 (no) Ny fremgangsmåte for fremstilling av oksabispidiner
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
IL158360A0 (en) Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives
NO20035586L (no) Fremgangsmate for fremstilling av cykloheksanol-derivater
NO20020059L (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO20042202L (no) Fremgangsmate for fremstilling av asymmetriske karotenoider
IL162770A (en) Process for the preparation of 7??-methyl-estr-4-ene-3-one derivatives
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
FR2826004B1 (fr) Procede de preparation de derives estrogenes
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20032297D0 (no) Fremgangsmåte for fremstilling av distamycinderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees